HPLC Method and Instrumentation
On this page
Direct answer
High performance liquid chromatography separates mixtures between a liquid mobile phase and a finely packed stationary phase under several hundred bar, and pharmacy runs overwhelmingly on reversed phase: a C18 column with aqueous buffer plus acetonitrile or methanol, where polar molecules elute first and retention grows with hydrophobicity. The instrument chain is degasser, pump (isocratic or gradient), injector with a fixed loop (20 microlitres typical), column — classically 250 × 4.6 millimetres packed with 5 micrometre particles, protected by a guard column — and detector: ultraviolet or photodiode-array for most drugs, fluorescence for trace analysis, refractive index for compounds without chromophores, electrochemical and mass spectrometric for the demanding end. Quality is judged chromatographically: plate number N = 16(tR/w)² measures efficiency, resolution Rs = 2(t2 − t1)/(w1 + w2) with 1.5 meaning baseline separation, retention factor k′ sits ideally 1-10, and Van Deemter's H = A + B/u + Cu explains the optimum flow. Pharmacopoeias lean on system suitability — replicate RSD within 2 per cent, controlled tailing — before any result counts.
What you must remember
- Mode logic: reversed phase (C18/C8, aqueous-organic) — polar elutes first; normal phase (silica, hexane) — nonpolar elutes first; the order reversal is the most-tested fact in the chapter.
- Column conventions: 150-250 × 4.6 millimetre analytical columns, 3-5 micrometre particles (sub-2 micrometre for UPLC at pressures to about 1,000 bar), with a sacrificial guard column ahead.
- Detector choice: UV/PDA for chromophores, fluorescence for sensitivity, refractive index universal but insensitive and gradient-incompatible, MS for identity plus quantification.
- Plate number: N = 16(tR/w)²; more plates, better efficiency — peaks narrow as N rises.
- Resolution: Rs = 2(t2 − t1)/(w1 + w2); 1.5 is baseline separation.
- System suitability (USP <621> convention): replicate injections typically RSD not more than 2.0 per cent, tailing factor contained (commonly not more than 2), adequate resolution between specified pairs — run before and during the assay.
- Gradient versus isocratic: isocratic for simple assays; gradient (rising organic fraction) for late-eluting impurities and complex matrices.
- Pharmacopoeial uses: assay against a reference standard, related substances, dissolution quantification, chiral separations on cyclodextrin phases — the IP/USP workhorse list.
Reading a chromatogram for an assay
Take a tablet assay by IP method. The blank runs first, then the standard: a symmetrical peak at 5.8 minutes sets the retention window. System suitability injects the standard five times; the printout shows RSD 0.6 per cent, tailing 1.1, N about 6,000 — all inside limits, so the sequence may proceed. Sample preparations inject in duplicate, and the assay falls out of a simple response comparison against the standard. Now the interpretation skills: the first sample shows a shoulder — the method's related-substances capability glimpsed inside an assay run, and quantifying that impurity would need the related-substances method with its own gradient and sensitivity. A second sample tails above 2: residual silanol interaction with a basic drug, managed with endcapped silica, a competing amine or pH control — the parameters robustness explores.
Development choices behind that run are worth narrating: selectivity tuned by organic fraction and pH (ionised analytes elute early), column chemistry and temperature; sensitivity by wavelength chosen from the PDA spectrum away from solvent cut-off — acetonitrile and water near 190 nanometres, methanol near 205. For plasma, protein precipitation precedes injection and an internal standard corrects preparation variability — the architecture of bioanalysis. Every step maps to a validation characteristic, which is why HPLC development and ICH validation are taught as one skill.
Where the exam sets its traps
Elution order is the perennial trap: state reversed phase and polar-first in the same sentence, because half the errors come from quoting normal-phase order under an RP question. Second, the refractive index detector: candidates propose it with gradient elution; it demands isocratic conditions because it senses any change in mobile-phase composition. Third, formulas without units: N = 16(tR/w)² works only when peak width and retention time share units, and Rs loses a mark if the factor of 2 or the paired widths are dropped. Fourth, system suitability versus calibration: suitability proves the system performs today for this method; calibration converts response to amount — distinct concepts that MCQs deliberately blur. Finally, know one modern fact — sub-2 micrometre particles at very high pressure (UPLC) shorten runs several-fold.
Frequently asked questions
Which compounds elute first in reversed-phase HPLC?
Polar compounds elute first because the nonpolar C18 stationary phase retains hydrophobic molecules more strongly; raising the organic fraction of the mobile phase elutes them faster.
What resolution separates two peaks to baseline?
An Rs of 1.5 gives baseline separation, calculated as 2(t2 − t1)/(w1 + w2); pharmacopoeial methods specify minimum resolution between critical pairs before results are acceptable.
What does system suitability testing verify?
That the complete system — column, mobile phase, detector and injector — performs to preset criteria (replicate RSD, tailing, plates, resolution) on the day of analysis, independent of method validation.
Why can a refractive index detector not be used with gradients?
It responds to any change in mobile-phase refractive index, so ramping organic composition swamps analyte signals; it is reserved for isocratic separations of compounds lacking chromophores.
What is the Van Deemter equation used for?
H = A + B/u + Cu describes band broadening versus flow: eddy diffusion, longitudinal diffusion and mass-transfer terms define an optimum velocity at which plate height is minimised.